{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-159910","form_type":"8-K","ticker":"IMA","cik":"0001835579","company_name":"ImageneBio, Inc.","filed_at":"2025-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.226375+00:00","generated_at":"2026-05-18T06:17:37.098780+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ikena Oncology amends executive’s equity vesting terms tied to pending Inmagene merger","bullets":["Effective July 15, 2025, Ikena Oncology amended employment agreement with Dr. Jotin Marango, an executive officer.","Amendment provides for full acceleration of time-based equity awards if termination without cause or resignation during change in control period.","Change in control period began March 18, 2025 (initial S-4 filing for merger with Inmagene) and ends 12 months post-merger.","Accelerated vesting effective later of termination date or change in control; forfeiture of unvested portions delayed until that date.","Contemplated merger with Inmagene Biopharmaceutics was announced December 23, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-159910","json":"https://secwatch.observer/filing/0001193125-25-159910.json","markdown":"https://secwatch.observer/filing/0001193125-25-159910.md","text":"https://secwatch.observer/filing/0001193125-25-159910.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835579/000119312525159910/0001193125-25-159910-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835579/000119312525159910/d948992d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:17:37.098780+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}